Shenzhen People's Second Hospital & The First Affiliated Hospital of Shenzhen University, Shenzhen, 518000, Guangdong, China; Southern University of Science and Technology, Shenzhen, 518055, Guangdong, China.
Southern University of Science and Technology, Shenzhen, 518055, Guangdong, China.
Biochem Biophys Res Commun. 2022 Dec 25;636(Pt 1):121-124. doi: 10.1016/j.bbrc.2022.10.056. Epub 2022 Oct 20.
IGF1R plays an important role in regulating cellular metabolism and cell growth, and has been identified as an anti-cancer and diabetes drug target. Although research have been reported many crystal and cryo-EM structures of IGF1R, the mechanism of ligand binding remains controversial, mainly because the structure differences among its cryo-EM, crystal and homologous protein insulin receptor structures. Here, we further determined one new high-resolution symmetric cryo-EM structure of ligand-bound IGF1R and be the first to prove that the receptor could bind to two IGFI molecules by single particle cryo-electron microscopy. And the structure is very different from its homologous protein insulin receptor: the two ligands just exist at the binding site 2 with saturating ligand conditions. Then, our findings resolved the major dispute about the comformational changes of IGF1R, and proposed a new theory how IGF1R binds to its ligands. Meanwhile, these findings imply more attention may be needed to study the relationship between the special conformation and their corresponding physiological functions in future.
IGF1R 在调节细胞代谢和细胞生长方面发挥着重要作用,已被确定为抗癌和糖尿病药物的靶点。尽管已经报道了 IGF1R 的许多晶体和 cryo-EM 结构,但配体结合的机制仍存在争议,主要是因为其 cryo-EM、晶体和同源蛋白胰岛素受体结构之间存在差异。在这里,我们进一步确定了一个新的配体结合 IGF1R 的高分辨率对称 cryo-EM 结构,并且首次通过单颗粒 cryo-EM 证明了受体可以通过单颗粒 cryo-EM 结合两个 IGFI 分子。该结构与同源蛋白胰岛素受体非常不同:在饱和配体条件下,两个配体仅存在于结合位点 2 处。然后,我们的发现解决了 IGF1R 构象变化的主要争议,并提出了一个新的理论,即 IGF1R 如何与其配体结合。同时,这些发现表明,未来可能需要更多关注研究特殊构象与其相应生理功能之间的关系。